NDC product
TESALON Tesaperlas Severe Cold Max Relief
NDC 69729-788 · OPMX LLC
Key facts
| Product NDC | 69729-788 |
|---|---|
| Proprietary name | TESALON Tesaperlas Severe Cold Max Relief |
| Nonproprietary name | Dextromethorphan HBr, Guaifenesin |
| Substances | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN |
| Dosage form | CAPSULE, LIQUID FILLED |
| Route | ORAL |
| Labeler | OPMX LLC |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M012 |
| Pharmacologic classes | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC] and 1 more |
| Marketing start | Sep 27, 2024 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: